Scholarlink

<p>Bovine rotavirus is one of the main pathogens causing acute diarrhea in calves under 1&#xa0;month of age, posing a serious threat to intensive cattle farming, and there are no effective therapeutic agents owing to the mixed infection of bovine rotavirus (BRV) with other pathogens. In this study, we successfully constructed a phage display antibody library by immunizing Bactrian camels, with a capacity of 6.5 × 10<sup>8</sup> and a recombinant positive rate of 81.25%. Three high-activity variable heavy-chain domains (VHH) were obtained by using BRV as the antigen, and the gene fragments were ligated with the prokaryotic expression vector pET–22b(+). The recombinant VHH was successfully expressed under induction by isopropyl β-<span>d</span>-1-thiogalactopyranoside (IPTG). In addition, the recombinant VHH could specifically bind to BRV in an enzyme-linked immunosorbent assay (ELISA) and cellular immunofluorescence assays. The neutralizing activity of VHH was further confirmed by a virus neutralization test. Furthermore, our data showed that recombinant VHH could alleviate symptoms such as diarrhea and high fever, and reduce the amount of virus release in a BRV-challenged calf model. These results suggest that the single-domain antibodies against BRV screened in this study offer an effective treatment in BRV infection, facilitating the development of novel therapeutics for BRV.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Potent neutralization and therapeutic efficacy of bovine rotavirus-specific VHH antibodies in infected calves

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月21日

查看全文
  • Qihuan Zhao,
  • Min Gao,
  • Puchen Li,
  • Bo Wang,
  • Baohui Li,
  • Gege Rile,
  • Chengquan Du,
  • Jingjing Wang,
  • Hui Wang,
  • Jingsi Mei,
  • Shujun Zhang,
  • Fuxiang Bao

摘要

Bovine rotavirus is one of the main pathogens causing acute diarrhea in calves under 1 month of age, posing a serious threat to intensive cattle farming, and there are no effective therapeutic agents owing to the mixed infection of bovine rotavirus (BRV) with other pathogens. In this study, we successfully constructed a phage display antibody library by immunizing Bactrian camels, with a capacity of 6.5 × 108 and a recombinant positive rate of 81.25%. Three high-activity variable heavy-chain domains (VHH) were obtained by using BRV as the antigen, and the gene fragments were ligated with the prokaryotic expression vector pET–22b(+). The recombinant VHH was successfully expressed under induction by isopropyl β-d-1-thiogalactopyranoside (IPTG). In addition, the recombinant VHH could specifically bind to BRV in an enzyme-linked immunosorbent assay (ELISA) and cellular immunofluorescence assays. The neutralizing activity of VHH was further confirmed by a virus neutralization test. Furthermore, our data showed that recombinant VHH could alleviate symptoms such as diarrhea and high fever, and reduce the amount of virus release in a BRV-challenged calf model. These results suggest that the single-domain antibodies against BRV screened in this study offer an effective treatment in BRV infection, facilitating the development of novel therapeutics for BRV.